Explanted diseased livers - A possible source of metabolic competent primary human hepatocytes

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Kleine, Moritz ^a   Riemer, Marc ^a   Krech, Till ^a   DeTemple, Daphne ^a   Jäger, Mark D ^a   Lehner, Frank ^a   Manns, Michael P ^a,b   Klempnauer, Jürgen ^a   Borlak, Jürgen ^a   Bektas, Hueseyin ^a   Vondran, Florian W R ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b German Centre for Infection Research (DZIF) Partner Site Hannover Braunschweig   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; 7 ETHOXYCOUMARIN DEETHYLASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 2C8; CYTOCHROME P450 3A4; GLUCURONOSYLTRANSFERASE; MESSENGER RNA; PHENOBARBITAL; RIFAMPICIN; UREA; ALBUMINOID; UNSPECIFIC MONOOXYGENASE;

ADULT; AGED; ARTICLE; CELL COUNT; CELL FUNCTION; CELL ISOLATION; CELL METABOLISM; CELL STRUCTURE; CELL VIABILITY; ENZYME ACTIVITY; ENZYME INDUCTION; EXPLANT; EXPLANTED DISEASED LIVER; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIMARY CELL CULTURE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; UREA CYCLE; YOUNG ADULT; BIOSYNTHESIS; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER DISEASE; METABOLISM; MIDDLE AGED; PATHOLOGY; SURGERY;

ADULT; AGED; ALBUMINS; ARYL HYDROCARBON HYDROXYLASES; CELL COUNT; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RNA, MESSENGER; UREA; YOUNG ADULT;

EID: 84904356208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101386     Document Type: Article

References (29)

1. Hewitt NJ (2010) Optimisation of the cryopreservation of primary hepatocytes. Methods Mol Biol 640: 83-105.
2. Katenz E, Vondran FW, Schwartlander R, Pless G, Gong X, et al. (2007) Cryopreservation of primary human hepatocytes: the benefit of trehalose as an additional cryoprotective agent. Liver transplantation 13: 38-45. (Pubitemid 46099972)
3. Gramignoli R, Dorko K, Tahan V, Skvorak KJ, Ellis E, et al. (2013) Hypothermic storage of human hepatocytes for transplantation. Cell transplantation: in press.
4. Fuller BJ, Petrenko AY, Rodriguez JV, Somov AY, Balaban CL, et al. (2013) Biopreservation of hepatocytes: current concepts on hypothermic preservation, cryopreservation, and vitrification. Cryo letters 34: 432-452.
5. Ramboer E, Vanhaecke T, Rogiers V, Vinken M (2013) Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters. Drug metabolism reviews 45: 196-217.
6. LeCluyse EL, Witek RP, Andersen ME, Powers MJ (2012) Organotypic liver culture models: meeting current challenges in toxicity testing. Critical reviews in toxicology 42: 501-548.
7. Guguen-Guillouzo C, Guillouzo A (2010) General review on in vitro hepatocyte models and their applications. Methods Mol Biol 640: 1-40.
8. Nguyen TH, Mainot S, Lainas P, Groyer-Picard MT, Franco D, et al. (2009) Ex vivo liver-directed gene therapy for the treatment of metabolic diseases: advances in hepatocyte transplantation and retroviral vectors. Current gene therapy 9: 136-149.
9. Kirchberg J, Reissfelder C, Weitz J, Koch M (2013) Laparoscopic surgery of liver tumors. Langenbeck's archives of surgery 398: 931-938.
10. Alexandre E, Cahn M, Abadie-Viollon C, Meyer N, Heyd B, et al. (2002) Influence of pre-, intra- and post-operative parameters of donor liver on the outcome of isolated human hepatocytes. Cell and tissue banking 3: 223-233. (Pubitemid 36950118)
11. Harring TR, O'Mahony CA, Goss JA (2011) Extended donors in liver transplantation. Clinics in liver disease 15: 879-900.
12. Vondran FW, Katenz E, Schwartlander R, Morgul MH, Raschzok N, et al. (2008) Isolation of primary human hepatocytes after partial hepatectomy: criteria for identification of the most promising liver specimen. Artificial organs 32: 205-213. (Pubitemid 351326754)
13. Lloyd TD, Orr S, Patel R, Crees G, Chavda S, et al. (2004) Effect of patient, operative and isolation factors on subsequent yield and viability of human hepatocytes for research use. Cell and tissue banking 5: 81-87. (Pubitemid 38961751)
14. Bhogal RH, Hodson J, Bartlett DC, Weston CJ, Curbishley SM, et al. (2011) Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PloS One 6: e18222.
15. Gramignoli R, Tahan V, Dorko K, Skvorak KJ, Hansel MC, et al. (2013) New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants. Stem cell research 11: 563-573.
16. Kehr DC, Raschzok N, Sauer IM (2012) A novel cannulation technique for isolation of human hepatocytes from explanted diseased whole livers. Transplantation proceedings 44: 999-1001.
17. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464-470. (Pubitemid 32119037)
18. Borlak J, Hock A, Hansen T, Richter E (2003) DNA adducts in cultures of polychlorinated biphenyl-treated human hepatocytes. Toxicology and applied pharmacology 188: 81-91. (Pubitemid 36416600)
19. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
20. Greenlee WF, Poland A (1978) An improved assay of 7-ethoxycoumarin Odeethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachloro- dibenzo- p-dioxin. The Journal of pharmacology and experimental therapeutics 205: 596-605. (Pubitemid 8393079)
21. Rogue A, Lambert C, Spire C, Claude N, Guillouzo A (2012) Interindividual variability in gene expression profiles in human hepatocytes and comparison with HepaRG cells. Drug metabolism and disposition: the biological fate of chemicals 40: 151-158.
22. Stephenne X, Najimi M, Sokal EM (2010) Hepatocyte cryopreservation: is it time to change the strategy? World journal of gastroenterology 16: 1-14.
23. Terry C, Dhawan A, Mitry RR, Lehec SC, Hughes RD (2010) Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation. Liver transplantation 16: 229-237.
24. Deurholt T, van Til NP, Chhatta AA, ten Bloemendaal L, Schwartlander R, et al. (2009) Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes. BMC biotechnology 9: 89.
25. Dolle L, Best J, Mei J, Al Battah F, Reynaert H, et al. (2010) The quest for liver progenitor cells: a practical point of view. Journal of hepatology 52: 117-129.
26. Freeman RB Jr, Gish RG, Harper A, Davis GL, Vierling J, et al. (2006) Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver transplantation 12: S128-136. (Pubitemid 44911794)
27. Quante M, Benckert C, Thelen A, Jonas S (2012) Experience Since MELD Implementation: How Does the New System Deliver? International journal of hepatology 2012: 264015.
28. Tariq H, Manzoor S, Parvaiz F, Javed F, Fatima K, et al. (2012) An overview: in vitro models of HCV replication in different cell cultures. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 12: 13-20.
29. Krause P, Unthan-Fechner K, Probst I, Koenig S (2013) Cultured hepatocytes adopt progenitor characteristics and display bipotent capacity to repopulate the liver. Cell transplantation: in press.